Journals / Turkish Journal of Surgery / 2018 / Cilt: 34 - Sayı: 2

Surgical approaches for papillary microcarcinomas: Turkey’s perspective

Pages
89–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The recommendation of active surveillance (follow-up without any interventionaltherapy) was limited with 9% responders.Conclusion: The results of the questionnaire demonstrated that there have been various choices in Turkey for thesurgical treatment of the papillary microcarcinomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size,has been increasing in the last decade.
📊
Key Findings & Data:Herein, we present internet-based questionnaire results performed by theTurkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillarymicrocarcinomas in Turkey.Material and Methods: The user-friendly questionnaire consisted of 13 questions in total.
💡
Conclusion & Impact:The recommendation of active surveillance (follow-up without any interventionaltherapy) was limited with 9% responders.Conclusion: The results of the questionnaire demonstrated that there have been various choices in Turkey for thesurgical treatment of the papillary microcarcinomas.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size,has been increasing in the last decade. Herein, we present internet-based questionnaire results performed by theTurkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillarymicrocarcinomas in Turkey.Material and Methods: The user-friendly questionnaire consisted of 13 questions in total. These questions mainlyaddressed the surgical management of nodules and cancer of <1 cm in size. Patient management before, during,and after surgical intervention was also included; additionally, the “active surveillance approach” was questioned.Results: There were 420 responders in total who were of multidisciplinary origin (endocrinologists, surgeons, nuclearmedicine specialists, pathologists, and oncologists). Total thyroidectomy was the predominant treatment approach(65%) for the classical type of microcarcinoma limited in one lobe, whereas in cases of microcarcinomasincidentally diagnosed during hemithyroidectomy, complementary surgery approach was advised by 40% of theresponders. The responders found capsule invasion (86%) and patient based management (94%) of high importance.The percentage of the responders who recommended radioactive iodine ablation in incidental cancers having noaggressive criteria was 51%. The survey participants that were against routine central dissection in these cases accountedfor 73% of the responders. The recommendation of active surveillance (follow-up without any interventionaltherapy) was limited with 9% responders.Conclusion: The results of the questionnaire demonstrated that there have been various choices in Turkey for thesurgical treatment of the papillary microcarcinomas.

🔖

Cite This Article

MAKAY, Ö., ÖZDEMİR, M., SENYUREK, Y. G., TUNCA, F., DÜREN, M., ULUDAĞ, M., İÇÖZ, G., İŞGÖR, A., ÖZBAŞ, S., ÖZCAN, Z., TEZELMAN, S. (2018). Surgical approaches for papillary microcarcinomas: Turkey’s perspective. Turkish Journal of Surgery, Cilt: 34 - Sayı: 2, 89–93. https://ajindex.com/articles/390552

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 Cancer 2009; 115: 3801-3807.
  2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 2006; 295: 2164 -2167. Wartofsky L. Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab. 2012; 97: 1169 -1172. [CrossRef] Haugen BR, Alexander Ek, Bible KC, Gerard M. Doherty, Susan J. Mandel, Yuri E. Nikiforov et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer Thyroid. 2016; 26: 1-133. [CrossRef] Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy Ann Surg. 1998; 228: 320-330. [CrossRef] Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124: 958-964. [CrossRe Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation Thyroid 2014; 24: 27-34. [CrossRef] Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y, Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes World J Surg 2010; 34: 1222-1231. [CrossRef] Untch BR, Palmer FL, Ganly I, Patel SG, Michael TR, Shah JP et al. Oncologic outcomes after completion thyroidectomy for patients with well- differentiated thyroid carcinoma Ann Surg Oncol. 2014; 21: 1374-1378. [CrossRef] Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES) Langenbecks Arch Surg. 2014; 399: 155-163. [CrossRef] Lupi C, Giannini R, Uglioni C, Proietti A, Berti P, Minuto M et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases ofpapillary thyroid carcinoma J Clin Endocrinol Metab. 2007; 92: 4085-4090. [CrossRef] Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G et al. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma Clin En- docrinol (Oxf ) 2006; 65: 364-368